Tushar Singh Barwal
Overview
Explore the profile of Tushar Singh Barwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar P, Kumawat R, Uttam V, Behera A, Rani M, Singh N, et al.
Transl Oncol
. 2022 Nov;
27:101573.
PMID: 36335706
Unfortunately, despite the severe problem associated with salivary adenoid cystic carcinoma (SACC), it has not been studied in detail yet. Therefore, the time has come to understand the oncogenic cause...
2.
Arora T, Prashar V, Singh R, Barwal T, Changotra H, Sharma A, et al.
Mol Neurobiol
. 2022 Jul;
59(10):6107-6124.
PMID: 35867206
Alzheimer's disease (AD) is a progressive degeneration of neurons due to the accumulation of amyloid-β peptide (Aβ) and hyper-phosphorylation of tau protein in the neuronal milieu leading to increased oxidative...
3.
Barwal T, Singh N, Sharma U, Bazala S, Rani M, Behera A, et al.
Cancer Treat Res Commun
. 2022 Jun;
32:100593.
PMID: 35752082
Accumulating evidence suggests the critical role of miR-590-5p in various aspects of cellular homeostasis, including cancer. Furthermore, we and others have recently demonstrated that miRNA-590-5p acts as an oncogene in...
4.
Rana M, Rana A, Sharma U, Barwal T, Jain A
Int J Breast Cancer
. 2022 Jun;
2022:4958580.
PMID: 35655582
Background: The frozen section (FS) has been a good technique in surgical management of breast lesions since many years. But complete agreement and cooperation have not been achieved everywhere among...
5.
Sharma U, Murmu M, Barwal T, Tuli H, Jain M, Prakash H, et al.
Curr Oncol
. 2022 Apr;
29(4):2326-2349.
PMID: 35448163
Despite the availability of modern techniques for the treatment of esophageal squamous cell carcinoma (ESCC), tumor recurrence and metastasis are significant challenges in clinical management. Thus, ESCC possesses a poor...
6.
Sharma U, Barwal T, Khandelwal A, Rana M, Rana A, Singh K, et al.
Front Oncol
. 2022 Mar;
12:823953.
PMID: 35237522
Background: Despite the availability of advanced technology to detect and treat esophageal squamous cell carcinoma (ESCC), the 5-year survival rate of ESCC patients is still meager. Recently, long non-coding RNAs...
7.
Sharma U, Barwal T, Murmu M, Acharya V, Pant N, Dey D, et al.
Biomark Med
. 2022 Feb;
16(5):349-369.
PMID: 35195032
Recently, long intergenic non-protein coding RNA 01133 () was identified as a novel transcript in cancers. It modulates various hallmarks of cancers and acts as oncogenic in some cancers while...
8.
Barwal T, Sharma U, Rana M, Bazala S, Singh I, Murmu M, et al.
Crit Rev Oncol Hematol
. 2022 Jan;
171:103598.
PMID: 35033662
Several studies have demonstrated the potential of circulating long non-coding RNAs (lncRNAs) as promising cancer biomarkers. Herein, we addressed the regulatory role of circulating lncRNAs and their potential value as...
9.
Aggarwal V, Tuli H, Varol M, Tuorkey M, Sak K, Parashar N, et al.
Crit Rev Oncol Hematol
. 2021 Jul;
164:103403.
PMID: 34214610
Notch signaling, an evolutionarily conserved signaling cascade, is critical for normal biological processes of cell differentiation, development, and homeostasis. Deregulation of the Notch signaling pathway has been associated with tumor...
10.
Barwal T, Sharma U, Bazala S, Singh I, Jain M, Prakash H, et al.
Int J Mol Sci
. 2021 Apr;
22(8).
PMID: 33920789
Aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane have shown to prevent metastasis and angiogenesis in estrogen receptor (ER)-positive breast and ovarian tumors. They function primarily by reducing estrogen...